site stats

Digoxin interstage mortality

WebMar 18, 2024 · Digoxin is used for the treatment of heart failure in pediatric patients and acts by controlling numerous functions of the cardiovascular system. Digoxin use in single ventricle congenital heart disease may decrease interstage mortality. The study will be conducted in approximately 48 subjects at approximately 13 investigational centers. WebFeb 23, 2024 · Digoxin use at the time of discharge was the preeminent protective feature against home interstage mortality both by univariate analysis and advanced ML. The protective effect of digoxin for interstage mortality, despite an unclear therapeutic mechanism, has been reported in several studies [ 9 , 17 , 32 ].

Propranolol Versus Digoxin in the Neonate for Supraventricular ...

WebNov 1, 2024 · Interstage mortality for those not on digoxin was 12.3%, compared to 2.9% among those on digoxin, with an adjusted hazard ratio of 3.5 (95% CI, 1.1–11.7; P=0.04). The number needed to treat to ... WebJan 26, 2016 · Interstage mortality for those not on digoxin was 12.3%, compared to 2.9% among those on digoxin, with an adjusted hazard ratio of 3.5 (95% CI, 1.1–11.7; P=0.04). The number needed to treat to ... kontraindikationen hydrotherapie https://mariamacedonagel.com

Kaplan–Meier survival curves for the no digoxin and digoxin …

WebJan 11, 2016 · typical mortality rates of 15% to 20% occurring around the stage 1 palliation (S1P), and interstage mortality (IM) rates of 10% to 15% in survivors discharged to … WebNational Center for Biotechnology Information WebSep 1, 2024 · The use of digoxin has been associated with significantly lower interstage mortality (ISM) following stage 1 palliation (S1P) of single ventricle heart disease. 1, 2 … kontraindikationen thrombolyse

Hazard Ratio for Interstage Mortality Download Table

Category:Association of Digoxin With Interstage Mortality: Results From …

Tags:Digoxin interstage mortality

Digoxin interstage mortality

Association of Digoxin With Interstage Mortality: Results From the ...

WebMar 6, 2024 · Patients with a serum digoxin concentration ≥1.2 ng/ml had a 56% increased hazard of mortality (adjusted HR, 1.56; 95% confidence interval [CI], 1.20–2.04). When analyzed as a continuous variable, serum digoxin concentration was associated with a 19% higher adjusted hazard of death for each 0.5 ng/ml increase (p = 0.0010); these results ... WebOct 1, 2024 · Interstage mortality is poorly understood and remains a high-risk period for patients with SVCHD. We present a validated risk score to predict interstage mortality that identified moderate or greater TR and a persistent supplemental O 2 requirement as the greatest risk subgroup. Interstage mortality may be impacted by intensifying …

Digoxin interstage mortality

Did you know?

WebJan 13, 2016 · Background: Mortality for infants with single ventricle congenital heart disease remains as high as 8% to 12% during the interstage period, the time between … WebDec 1, 2024 · The impact of digoxin on interstage mortality remains unproven. Abstract. The use of Digoxin has been associated with improved interstage survival following …

WebJan 1, 2016 · Digoxin use in infants with single ventricle congenital heart disease is associated with significantly reduced interstage mortality, and the number needed to treat to prevent 1 death was 11 patients. Background Mortality for infants with single ventricle congenital heart disease remains as high as 8% to 12% during the interstage period, the … WebQuality improvement efforts have focused on reducing interstage mortality for infants with hypoplastic left heart syndrome (HLHS). In 1/2016, two publications reported that use of digoxin was associated with reduced interstage mortality. The degree to which these findings have affected real world pr …

WebApr 11, 2024 · cardiac function , digoxin , echocardiogram , interstage mortality , interstage period , single-ventricle congenital heart disease Search for Similar Articles … WebMay 4, 2024 · Effect of Digoxin on Interstage Outcomes following Stage I Palliation for Functionally Univentricular Hearts: A Systematic Review and Meta-Analysis May 2024 DOI: 10.1101/2024.05.04.22274522

WebMar 1, 2024 · Background Infants born with single right ventricle congenital heart disease (SVCHD) physiology, such as hypoplastic left heart syndrome and variants, are at a high risk for death or transplant during the interstage (IS) defined as the period between Stage 1 surgery (aorto-pulmonary shunt with arch reconstruction) and Stage 2 surgery (superior …

WebThe protective effect of digoxin for interstage mortality, despite an unclear therapeutic mechanism, has been reported in several studies [9, 17,32]. Based largely on these reports, the use of ... kontraindikation infusionstherapieWebInterstage mortality was 9.4%. Digoxin use was associated with lower risk of death (P =.03) on univariable analysis, however no single medication was an independent predictor on regression analysis. Change in weight-for-age z-score was studied as outcome of somatic growth with 36.3% patients showing a decrease during the interstage period. kontraindikationen psychotherapieWebFeb 2, 2024 · Quality improvement efforts have focused on reducing interstage mortality for infants with hypoplastic left heart syndrome (HLHS). In 1/2016, two publications reported that use of digoxin was associated with reduced interstage mortality. The degree to which these findings have affected real world practice has not been evaluated. The discharge … kontraindikation niv therapieWebJan 11, 2016 · Interstage mortality by surgical site (n=50 centers). This figure shows interstage mortality (IM) among the 544 infants in the … kontraindikation psychotherapieWebJan 26, 2016 · Interstage mortality for those not on digoxin was 12.3%, compared to 2.9% among those on digoxin, with an adjusted hazard ratio of 3.5 (95% CI, 1.1–11.7; … kontraindikation tracheostomaWebDigoxin has been associated with reduced interstage mortality after Norwood procedure. We sought to determine its association with survival and change in weight-for-age Z-score (WAZ) before the ... kontraindikation kompressionstherapieWebQuality improvement efforts have focused on reducing interstage mortality for infants with hypoplastic left heart syndrome (HLHS). In 1/2016, two publications reported that use of digoxin was associated with reduced interstage mortality. The degree to which these findings have affected real world practice has not been evaluated. kontraindikation physiotherapie